You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
據報內地擬清查醫美行業 主要針對醫院財務問題
阿思達克 09-19 15:06
內媒引述消息報道,內地有關部門將對醫美行業進行清查,涉及B端機構和上游,所有的醫療美容醫院和上游都會有相應的動作,清查方向分為稅務、工商及衛監(產品),是次力度比較大。 據悉,內地有關方面連夜召開醫美工作會議,可能是全國針對醫美的執法標準開始,主要針對醫院財務問題。內部會議主要要求執法現場查看醫美機構財務部門電腦中的電子文檔和表格,查找「團隊」、「客服」返款的明細賬單以及相關合作協議;查看醫美機構開戶銀行賬單的來網明細,對個別有嫌疑的條目進行深入核查;查看醫美機構客戶名單,一般醫美機構會建立詳細檔案,對其客戶進行精細分類以便開展後續營銷,如果客戶是熟人介紹等,應重點核查。 消息指出,是次清查的起因是杭州千和,杭州千和早前查稅47個億的漏稅,罰款8,500多萬元人民幣,而該機構的實際控制人為網紅老闆娘于文紅。 就此,愛美客(300896.SH)表示目前尚未有確鑿的政策端消息,公司經營沒有變化,認為醫療美容行業監管趨嚴,將引導和規範行業健康有序發展,行業中游龍頭企業、目前已規範化營運的醫療美容機構將獲得更多市場機會,有利於加速行業出清,推動醫療美容行業高質量發展。 華熙生物(688363.SH)內部人士指出,內地醫美概念股大跌或跟行業整頓有關,但對公司的影響應微乎其微,因公司主要還是一家生物科技公司,醫美佔營業額不到10%。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account